Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL632010 | 0.83 | — | — | |
| SCHEMBL8611744 | 0.78 | CYP2C9 (0.32) | CYP2C9CYP2C19 | |
| SCHEMBL6343777 | 0.75 | CYP2C9 (0.34) | CYP2C9CYP2C19 | |
| SCHEMBL2783694 | 0.73 | — | — | |
| SCHEMBL28677614 | 0.73 | CYP2C9 (0.30) | CYP2C9CYP2C19 | |
| SCHEMBL11427381 | 0.72 | CA12 (0.46) | CYP2C9CYP2C19 | |
| SCHEMBL11420579 | 0.72 | CYP2C9 (0.37) | CYP2C9CYP2C19 | |
| SCHEMBL27383862 | 0.70 | CA12 (0.55) | CYP2C9CYP2C19 | |
| SCHEMBL27574922 | 0.70 | CYP2C9 (0.41) | CYP2C9CYP2C19 | |
| SCHEMBL27852691 | 0.69 | CASP2 (0.41) | CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112480402-A | Modified polyaniline material, preparation method and application thereof | 黄寅福 | 2021-03-12 | — | — | CN | claimed |
| EP-2922893-B1 | MOISTURE-CURING COMPOSITIONS, PROCESSES FOR PRODUCING SAME AND USE OF SAME | EVONIK DEGUSSA GMBH (DE) | 2016-04-06 | — | — | EP | claimed |
| US-20150284609-A1 | MOISTURE-CURING COMPOSITIONS, PROCESS FOR PRODUCTION THEREOF AND USE THEREOF | EVONIK INDUSTRIES AG (DE) | 2015-10-08 | — | — | US | claimed |
| EP-2922893-A1 | MOISTURE-CURING COMPOSITIONS, PROCESSES FOR PRODUCING SAME AND USE OF SAME | Evonik Degussa GmbH (DE) | 2015-09-30 | — | — | EP | claimed |
| WO-2014079613-A1 | MOISTURE-CURING COMPOSITIONS, PROCESSES FOR PRODUCING SAME AND USE OF SAME | EVONIK INDUSTRIES AG (DE) | 2014-05-30 | — | — | WO | claimed |
| JP-4773373-B2 | — | — | 2011-09-14 | — | — | JP | claimed |
| JP-2007520606-A | — | — | 2007-07-26 | — | — | JP | claimed |
| EP-1711563-A2 | ACRYLATE-BASED PREPARATION CONTAINING ORGANOSILICIUM UNITS, METHOD FOR PREPARING SAME AND USE THEREOF | Degussa GmbH (DE) | 2006-10-18 | — | — | EP | claimed |
| EP-1304345-B1 | Aminoalkylalkoxysiloxan containing mixtures , their preparation process and their use | DEGUSSA (DE) | 2005-12-14 | — | — | EP | claimed |
| WO-2005075485-A2 | ACRYLATE-BASED PREPARATION CONTAINING ORGANOSILICIUM UNITS, METHOD FOR PREPARING SAME AND USE THEREOF | DEGUSSA AG (DE) | 2005-08-18 | — | — | WO | claimed |
| US-6770327-B2 | Aminoalkylalkoxysiloxane mixtures | DEGUSSA AG (DE) | 2004-08-03 | — | — | US | claimed |
| EP-0997469-B1 | Aminopropyl-functional siloxane oligomers | DEGUSSA (DE) | 2004-07-14 | — | — | EP | claimed |
| EP-1304345-A2 | Aminoalkylalkoxysiloxan containing mixtures , their preparation process and their use | Degussa AG (DE) | 2003-04-23 | — | — | EP | claimed |
| US-20030072873-A1 | Aminoalkylalkoxysiloxane mixtures | DEGUSSA AG (DE) | 2003-04-17 | — | — | US | claimed |
| US-6395858-B1 | AMINOALKYLSILANOL AND SIMILAR COMPOUNDS | DEGUSSA AG (DE) | 2002-05-28 | — | — | US | claimed |
| EP-0997469-A2 | Aminopropyl-functional siloxane oligomers | Degussa-Hüls Aktiengesellschaft (DE) | 2000-05-03 | — | — | EP | claimed |
| US-20230321717-A1 | FOUNDRY MIX INCLUDING RESORCINOL | Novis Works, LLC (US) | 2023-10-12 | — | — | US | disclosed |
| US-11712735-B2 | Foundry mix including resorcinol | Novis Works, LLC (US) | 2023-08-01 | — | — | US | disclosed |
| US-6395858-B1 | AMINOALKYLSILANOL AND SIMILAR COMPOUNDS | DEGUSSA AG (DE) | 2002-05-28 | — | — | US | disclosed |
| EP-0997469-A2 | Aminopropyl-functional siloxane oligomers | Degussa-Hüls Aktiengesellschaft (DE) | 2000-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11712735-B2 | Foundry mix including resorcinol | PRRC2C, RCOR1, ASH2L | CYP2C9 1729/4885CYP2C19 2814/4885 |
| US-20230321717-A1 | FOUNDRY MIX INCLUDING RESORCINOL | PRRC2C, ASH2L, RCOR1 | CYP2C9 1602/4885CYP2C19 2779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.